Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Alveolar injury and regeneration following deletion of ABCA3
Tara N. Rindler, … , James P. Bridges, Jeffrey A. Whitsett
Tara N. Rindler, … , James P. Bridges, Jeffrey A. Whitsett
Published December 21, 2017
Citation Information: JCI Insight. 2017;2(24):e97381. https://doi.org/10.1172/jci.insight.97381.
View: Text | PDF
Research Article Pulmonology

Alveolar injury and regeneration following deletion of ABCA3

  • Text
  • PDF
Abstract

Adaptation to air breathing after birth is dependent upon the synthesis and secretion of pulmonary surfactant by alveolar type 2 (AT2) cells. Surfactant, a complex mixture of phospholipids and proteins, is secreted into the alveolus, where it reduces collapsing forces at the air-liquid interface to maintain lung volumes during the ventilatory cycle. ABCA3, an ATP-dependent Walker domain containing transport protein, is required for surfactant synthesis and lung function at birth. Mutations in ABCA3 cause severe surfactant deficiency and respiratory failure in newborn infants. We conditionally deleted the Abca3 gene in AT2 cells in the mature mouse lung. Loss of ABCA3 caused alveolar cell injury and respiratory failure. ABCA3-related lung dysfunction was associated with surfactant deficiency, inflammation, and alveolar-capillary leak. Extensive but incomplete deletion of ABCA3 caused alveolar injury and inflammation, and it initiated proliferation of progenitor cells, restoring ABCA3 expression, lung structure, and function. M2-like macrophages were recruited to sites of AT2 cell proliferation during the regenerative process and were present in lung tissue from patients with severe lung disease caused by mutations in ABCA3. The remarkable and selective regeneration of ABCA3-sufficient AT2 progenitor cells provides plausible approaches for future correction of ABCA3 and other genetic disorders associated with surfactant deficiency and acute interstitial lung disease.

Authors

Tara N. Rindler, Courtney A. Stockman, Alyssa L. Filuta, Kari M. Brown, John M. Snowball, Wenjia Zhou, Ruud Veldhuizen, Erika M. Zink, Sydney E. Dautel, Geremy Clair, Charles Ansong, Yan Xu, James P. Bridges, Jeffrey A. Whitsett

×

Figure 1

Deletion of Abca3 in AT2 cells causes respiratory failure.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of Abca3 in AT2 cells causes respiratory failure.
(A) Quantitat...
(A) Quantitative PCR of Abca3 mRNA in whole lungs from adult control (black circles) and Abca3-cKO (red triangles) mice. (B) Abca3 mRNA in purified AT2 cells following 6 days of tamoxifen. Abca3 probes for exon 5–6 (A) and exon 3–4 (B), normalized to β-actin. Mean ± SEM, **P < 0.001, *P < 0.02 as determined by 1-way ANOVA, n = 4–8/group. Confocal immunofluorescence staining for ABCA3 (green) and proSPC (red) in control (C) and Abca3-cKO mice after 8 (D) and 11 days of tamoxifen (E). Scale bars: 50 μm. Inset cell scale bars: 5 μm. (F) Kaplan-Meier curve and statistical analysis (Wilcoxon-Gehan test) for control (black, n = 16) and Abca3-cKO (red, n = 30) mice, P < 0.0001. Representative lung histology of control (G and K) and Abca3-cKO mice after 4 (H and L), 7 (I and M), and 11 days of tamoxifen (J and N). Scale bars: 500 μm (G, H, I, and J) and 100 μm (K, L, M, and N), n = 3–4/group.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts